NCT04905251 - Effectiveness and Safety of Combination Mifepristone/Misoprostol for Medical Abortion | Biotech Hunter

Enrollment

129

Participants

Timeline

Start Date

February 19, 2022

Primary Completion Date

February 20, 2024

Study Completion Date

February 20, 2024

Conditions

Medical Abortion

Interventions

DRUG

Mifepristone-Misoprostol

Non interventional design.

Trial Locations (6)

Family Planning Clinic, Moncton City Hospital, Moncton

Centennial Primary Care, Kentville

Mud Creek Medical, New Minas

Manitoulin Health Centre, Mindemoya

Women's College Hospital, Toronto

Choice in Health Clinic, Toronto